Background illustration for clinical trials search

Paid Clinical Trials El Paso

Discover 885 paid clinical trials in El Paso, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 885

DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

for

Pulmonary Hypertension Due to Lung Diseases and Hypoxia,

Location: Denver CO, Aurora CO, Albuquerque NM, Salt Lake City UT,

Sponsor: United Therapeutics

Sex: All

Age: 18+

Code: NCT06388421

Recruiting

A Phase II Study of Ensifentrine in Non-Cystic Fibrosis Bronchiectasis

for

Non-cystic Fibrosis Bronchiectasis

Location: Denver CO, Kansas City KS, Rochester MN, Iowa City IA,

Sponsor: Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA

Sex: All

Age: 18 - 70+

Code: NCT06559150

Phase 2, Recruiting

4D-710 in Adult Patients With Cystic Fibrosis

for

Cystic Fibrosis Lung

Location: Denver CO, Kansas City KS, Tucson AZ, Dallas TX,

Sponsor: 4D Molecular Therapeutics

Sex: All

Age: 18+

Code: NCT05248230

Phase 2, Recruiting

Health Outcomes of Parents With Cystic Fibrosis-Aim 2

for

Cystic Fibrosis, Parenthood Status

Location: Denver CO, Kansas City KS, Dallas TX, Minneapolis MN,

Sponsor: University of Pittsburgh

Sex: All

Age: 18+

Code: NCT06296394

Recruiting

A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)

for

Carcinoma, Non-Small-Cell Lung

Location: Denver CO, Springdale AR, Dallas TX, Cedar Rapids IA,

Sponsor: Mirati Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT06875310

Phase 3, Recruiting

A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis

for

Idiopathic Pulmonary Fibrosis (IPF)

Location: Denver CO, Salt Lake City UT, El Paso TX,

Sponsor: Rein Therapeutics

Sex: All

Age: 40+

Code: NCT06968845

Phase 2, Recruiting

Phase 2b Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food Allergy

for

Ig-E Mediated Food Allergy

Location: Denver CO, Aurora CO, Colorado Springs CO, Phoenix AZ,

Sponsor: RAPT Therapeutics, Inc.

Sex: All

Age: 12 - 55

Code: NCT07220811

Phase 2, Recruiting

Prevention of Ototoxicity in NTM Patients Treated With IV Amikacin

for

Ototoxicity, Drug-Induced

Location: Denver CO, Tyler TX, San Francisco CA, Portland OR,

Sponsor: Kevin Winthrop

Sex: All

Age: 18 - 70+

Code: NCT05730283

Phase 2, Recruiting

A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators

for

Cystic Fibrosis

Location: Denver CO, Aurora CO, Salt Lake City UT, Billings MT,

Sponsor: Nicole Hamblett

Sex: All

Age: 12+

Code: NCT06504589

Recruiting

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

for

Muscle Invasive Bladder Urothelial Carcinoma,

Location: Denver CO, Aurora CO, Littleton CO, Highlands Ranch CO,

Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT07097142

Phase 3, Recruiting

Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial

for

Muscle Invasive Bladder Urothelial Carcinoma,

Location: Denver CO, Aurora CO, Highlands Ranch CO, Lone Tree CO,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT07061964

Phase 2, Recruiting

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

for

Prostate Cancer (Adenocarcinoma)

Location: Denver CO, Aurora CO, Lakewood CO, Highlands Ranch CO,

Sponsor: Canadian Cancer Trials Group

Sex: Male

Age: 18+

Code: NCT06592924

Phase 3, Recruiting

Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial

for

Metastatic Renal Cell Carcinoma,

Location: Denver CO, Aurora CO, Highlands Ranch CO, Lone Tree CO,

Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT05327686

Phase 2, Recruiting

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

for

Locally Advanced Lung Non-Small Cell Carcinoma,

Location: Denver CO, Aurora CO, Highlands Ranch CO, Lone Tree CO,

Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT05624996

Phase 3, Recruiting

Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer

for

Renal Pelvis and Ureter Urothelial Carcinoma

Location: Denver CO, Aurora CO, Highlands Ranch CO, Lone Tree CO,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT04628767

Phase 2, Phase 3, Recruiting

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

for

Clear Cell Renal Cell Carcinoma, Renal Cell Carcinoma (RCC),

Location: Denver CO, Aurora CO, Highlands Ranch CO, Lone Tree CO,

Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT06661720

Phase 3, Recruiting

Maestro 1.1 Post-Market Registry

for

Surgery

Location: Denver CO, Cedar Park TX, Jacksonville FL, Orlando FL,

Sponsor: Moon Surgical

Sex: All

Age: 18 - 70+

Code: NCT06103136

Recruiting

A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.

for

Breast Cancer

Location: Denver CO, Englewood CO, Lakewood CO, Thornton CO,

Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07062965

Phase 3, Recruiting

Study of ALTO-300 in MDD

for

Major Depressive Disorder

Location: Denver CO, Albuquerque NM, Phoenix AZ, Las Vegas NV,

Sponsor: Alto Neuroscience

Sex: All

Age: 18 - 70

Code: NCT05922878

Phase 2, Recruiting

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1

for

Non-Small Cell Lung Cancer

Location: Denver CO, Aurora CO, Lone Tree CO, Loveland CO,

Sponsor: Summit Therapeutics

Sex: All

Age: 18+

Code: NCT06767514

Phase 3, Recruiting

Paid Clinical Trials El Paso

Filter results

DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

A Phase II Study of Ensifentrine in Non-Cystic Fibrosis Bronchiectasis

4D-710 in Adult Patients With Cystic Fibrosis

Health Outcomes of Parents With Cystic Fibrosis-Aim 2

A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)

Interested in new trials?

A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis

Phase 2b Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food Allergy

Prevention of Ototoxicity in NTM Patients Treated With IV Amikacin

A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

Maestro 1.1 Post-Market Registry

A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.

Study of ALTO-300 in MDD

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1